TrialEuropean journal of cancer (Oxford, England : 1990)2021

Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.

Yuan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.